Background Combined oral contraceptives (COC s) containing various progestogens could
be associated with differential risks for venous thromboembolism (VTE). Objective To …

While venous thromboembolism (VTE) is rare in young women of reproductive age,
combined oral contraceptives increase the risk of VTE. In the patient in whom combined …

Recent data indicate that users of third-generation oral contraceptives, those containing the
new progestins desogestrel, gestodene, and norgestimate, have 2 to 3 times the risk of …

Epidemiologic data support the notion that first-generation high-dose oral contraceptives
(containing> 80 μg of estrogen) increased the incidence of thromboembolic events. The …

Aims To estimate the risk of venous thromboembolism among women prescribed the oral
contraceptive pill who have acute clinical conditions such as lower limb fractures, compared …

The lifetime incidence of venous throm-boembolism for both men and women is estimated at
1 per 1000. 1 Increasing our understanding of the precipitating risk factors, as well as …

The search for a safe and effective method of contraception has been ongoing for centuries.
During the last century, a variety of hormonal contraceptives, including combined hormonal …

PIP: Studies on the adverse effects of oral contraceptives (OCs) on blood clotting in which
selected groups of women taking OCs were monitored for coagulation and platelet changes …

A matched case-control study was undertaken in 10 centers in Germany and the United
Kingdom to explore the association of current use of major combination oral contraceptives …

Acta Obstet Gynecol Scand 2002; 81: 482-490.© Acta Obstet Gynecol Scand 2002
Background. Recent studies have indicated that the risk of thromboembolic disease (VTE) in …